Intratio
Quantitative Research
Skip to main content
AI Market Summary
Loading market intelligence...
  • Sign in
    My account
    Logout
AI 90-DAY FORECAST
NEUTRAL SIGNAL
██.█% Sign up free to reveal

Bio-Path Holdings, Inc. (BPTH) AI Forecast

Our AI analyzed Bio-Path Holdings, Inc.. Create a free account and follow it to see the 90-day price prediction.

✓ Free account • ✓ 30-day free trial

$BPTH Neutral Signal Full forecast available
Sign Up Free

Bio-Path Holdings, Inc. (BPTH) Stock Forecast Aug. 25, 2026

Bio-Path Holdings, Inc. (BPTH) AI Stock Price Forecast & Investment Analysis

Bio-Path Holdings, Inc. Stock Price Chart and Technical Analysis

Loading chart...

Bio-Path Holdings, Inc. (BPTH) - Comprehensive Stock Analysis & Investment Research

Deep dive into Bio-Path Holdings, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Analysis updated on August 25, 2026, 9:29 p.m. (UTC)

Bio-Path Holdings, Inc. Investment Summary

When evaluating whether Bio-Path Holdings, Inc. (BPTH) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.

Company Profile

Bio-Path Holdings, Inc. (BPTH) operates within the Life Sciences sector, specifically in the Pharmaceutical Preparations industry. . With a market capitalization of $2 million, the company is a small-cap stock that may offer higher growth potential but also carries higher volatility.

Financial Performance Analysis

Our comprehensive financial analysis covers Bio-Path Holdings, Inc.'s revenue, profitability metrics, balance sheet strength, and cash flow generation...

AI Price Predictions

Get AI-powered 7-day, 30-day and 90-day price forecasts for Bio-Path Holdings, Inc. along with confidence scores and detailed analysis...

Investment Considerations

Expert analysis of whether Bio-Path Holdings, Inc. is suitable for your investment objectives, risk tolerance, and time horizon...

Continue Reading Full Analysis

Get the complete investment breakdown for Bio-Path Holdings, Inc.

Sign Up Free
Corporate Identity

Bio-Path Holdings, Inc. (Stock Symbol: BPTH) is a prominent company operating within the Life Sciences sector, with a specific focus on the Pharmaceutical Preparations industry. The company's shares are publicly traded on the OTC exchange.

Leadership & Workforce

Detailed information about Bio-Path Holdings, Inc.'s leadership team, workforce size, and organizational structure...

Market Classification

Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Bio-Path Holdings, Inc....

Sector & Industry Analysis

In-depth sector dynamics and industry context for Bio-Path Holdings, Inc....

Unlock Full Company Profile

Get complete details about Bio-Path Holdings, Inc.

Sign Up Free
Revenue & Growth Analysis
Profitability Metrics

Net profit margin, gross margin, and operating margin analysis for Bio-Path Holdings, Inc....

Market Valuation

P/E ratio, price-to-book, and valuation multiples for Bio-Path Holdings, Inc....

Return Metrics

Return on equity (ROE), return on assets (ROA), and capital efficiency for Bio-Path Holdings, Inc....

Unlock Financial Analysis

Get complete financial metrics for Bio-Path Holdings, Inc.

Sign Up Free
AI ANALYSIS AVAILABLE

Unlock Bio-Path Holdings, Inc.'s AI Price Forecast

Join 10,000+ investors using our 67%+ accurate AI predictions

4,000+ Stocks Analyzed
67%+ Accuracy Rate
Daily Updates
Start 30-Day Free Trial →

✓ 30-day free trial • ✓ Cancel anytime

Strategic Market Position

Bio-Path Holdings, Inc. strategically competes in the highly dynamic Pharmaceutical Preparations marketplace. As a small-cap company, it represents an emerging market participant with potentially significant growth opportunities. Small-caps often offer greater growth potential as they capture market share and scale their operations, though this comes with higher risk and volatility. Success at this stage can lead to substantial returns for early investors who identify winning business models.

Industry Competitive Landscape

Bio-Path Holdings, Inc. competes within the Life Sciences sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.

Operational Efficiency
Financial Strength & Leverage

Current ratio of 0.07 reflects potential liquidity concerns with current liabilities exceeding current assets. While some businesses operate successfully with negative working capital, this warrants understanding of the specific circumstances.

Bio-Path Holdings, Inc. (BPTH) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Bio-Path Holdings, Inc. stock analysis.

Deep dive into Bio-Path Holdings, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Bio-Path Holdings, Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Bio-Path Holdings, Inc.:

Market Cap $2M
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Bio-Path Holdings, Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Bio-Path Holdings, Inc.: An ROE of 388.5% demonstrates excellent shareholder value creation.

ROE 388.5%
ROA -4869.1%
ROIC 403.9%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Bio-Path Holdings, Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Bio-Path Holdings, Inc.: A current ratio of 0.07 suggests potential liquidity concerns.

Current Ratio 0.07x
D/E Ratio -1.08x
Financial Leverage -0.08x
Interest Coverage -152.1x
Working Capital -$8M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Bio-Path Holdings, Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Bio-Path Holdings, Inc.:

Operating Cash Flow -$17M
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Bio-Path Holdings, Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Bio-Path Holdings, Inc.:

Understanding Financial Statement Data

What these metrics mean: Key figures from Bio-Path Holdings, Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Bio-Path Holdings, Inc.:

Income Statement
Operating Income -$34M
Net Income -$32M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 1%
Cash & Short-term Investments 0%
Total Liabilities 9%
Short-term Debt 4%
Dividend & Shareholder Information
Shares Outstanding 50M

Latest Bio-Path Holdings, Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Bio-Path Holdings, Inc. (BPTH) stock price and investment outlook.

📰 Loading...

Where BPTH sits on the market map

Explore the map →

Bio-Path Holdings, Inc. Competitors & Peer Analysis - Life Sciences Sector

Comparative analysis of Bio-Path Holdings, Inc. against industry peers and competitors in the Life Sciences sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
AAGH ██% N/A x x
AARD ██% $159M x 2.1x
ABBV ██% $469.99B 74.5x x
ABCL ██% $3.83B x 4.3x
ABEO ██% $355M x 2.8x
ABT ██% $202.24B 32.2x 3.9x
ABUS ██% $1.03B 6.7x 4.0x
ABVC ██% $21M x 2.0x
ABVX ██% $9.26B x x
ACAD ██% $5.26B 13.8x 4.0x
ACET ██% $84M x 0.7x
ACRS ██% $914M x 7.3x
ACRV ██% $93M x 1.1x
ACUT ██% $3M x x
ACXP ██% $7M x 0.8x
ADAG ██% $252M x 6.7x
ADCT ██% $133M x x
ADIL ██% $15M x x
ADTX ██% $6M x x
ADXN ██% $5M x x
AEON ██% $11M x x
AGIO ██% $2.02B x 2.0x
AKBA ██% $260M x 10.4x
AKTX ██% $15M x 0.8x
ALDX ██% $94M x 2.5x
ALKS ██% $8.24B 124.7x 4.6x
ALLR ██% $21M x 6.0x
ALMS ██% $3.06B x 6.8x
ALNY ██% $32.11B 40.0x 23.7x
ALT ██% $622M x 1.3x
ALXO ██% $276M x 2.0x
ALZN ██% $8M x 10.5x
AMLX ██% $4.17B x 17.4x
AMPH ██% $935M 11.9x 1.2x
AMRN ██% $299M x 0.7x
AMRX ██% $5.72B 36.4x 173.2x
ANAB ██% $1.69B x 132.9x
ANEB ██% $13M x 1.6x
ANIP ██% $1.60B 14.8x 2.7x
ANIX ██% $124M x 8.6x
ANNX ██% $1.04B x 5.6x
ANRO ██% $1.42B x 6.5x
ANTX ██% $206M x 2.7x
ANVS ██% $78M x x
APLM ██% $77M x x
APRE ██% $12M x 0.3x
APUS ██% $8M x 0.1x
APVO ██% $4M x 0.7x
AQST ██% $631M x x
ARCT ██% $408M x 2.4x
ARDX ██% $969M x 6.5x
ARQT ██% $3.11B 109.1x 14.1x
ARTL ██% $3M x 0.6x
ARVN ██% $610M 65.6x 1.1x
ARWR ██% $12.29B x 26.4x
ASBP ██% $11M x 0.9x
ASMB ██% $682M x 2.2x
ASND ██% $15.62B x x
ASRT ██% $151M x 2.0x
ATAI ██% $2.74B x 17.1x
ATHE ██% $83M x x
ATNM ██% $34M 1.3x 1.1x
ATOS ██% $26M x 1.0x
ATXI ██% $850K x 1.5x
AUPH ██% $2.20B 7.0x 3.6x
AVBP ██% $1.48B x 4.0x
AVIR ██% $438M x 2.2x
AVTX ██% $1.03B x 2.3x
AXIM ██% $1M x x
AXSM ██% $10.87B x 130.4x
AZTR ██% $10M x 1.3x
BBIO ██% $15.83B x x
BBOT ██% $732M x 2.3x
BCAX ██% $1.55B x 3.3x
BCTX ██% $30M x 1.3x
BCYC ██% $306M x 0.6x
BDPT ██% $20K x x
BDRX ██% $1M x x
BFRG ██% $10M x 1.5x
BFRI ██% $21M x 3.5x
BHC ██% $2.50B x x
BHST ██% $46M x 1.8x
BIOA ██% $434M x 1.2x
BIOE ██% $13M 8.9x 5.7x
BIOM ██% $520K x x
BIVI ██% $18M x 1.8x
BIXT ██% $2M x x
BLRX ██% $12M x x
BLTE ██% $6.25B x 8.1x
BMEA ██% $119M x 9.8x
BMRN ██% $12.59B 172.6x 2.0x
BMY ██% $137.39B 14.8x 6.2x
BNTC ██% $437M x 2.4x
BOLD ██% $66M x 1.0x
BOLT ██% $7M x 0.6x
BPTH ██% $2M x x
BQST ██% $2M x x
BRNS ██% $25M x 0.4x
BSPK ██% $10K x x
BTAI ██% $25M x x
BYSI ██% $29M x x
CALC ██% $17M x 3.1x
CANF ██% $7M x 1.3x
CAPR ██% $472M x 1.9x
CATX ██% $364M x 1.1x
CBIO ██% $641M x 5.9x
CDT ██% $2M x 0.0x
CING ██% $79M x 3.4x
CLCS ██% $65M x x
CLNN ██% $57M x x
CLRB ██% $24M x 0.8x
CLSDQ ██% $1M x x
CLYM ██% $942M x 3.9x
CMMB ██% $17M x 1.4x
CMND ██% $2M x x
CMPS ██% $2.01B x 23.8x
CNBX ██% N/A x x
CNSP ██% $9M x 0.5x
CNTA ██% $6.27B x 12.9x
CNTB ██% $145M x 5.4x
CNTX ██% $43M x 1.1x
COCP ██% $22M x 21.0x
COGT ██% $6.22B x 11.7x
COLL ██% $896M 18.7x 2.9x
CORT ██% $12.88B 233.5x 18.3x
COYA ██% $114M x 2.6x
CPHI ██% $38M x 1.1x
CPIX ██% $126M x 7.2x
CPMD ██% $1M x x
CPRX ██% $3.85B 17.4x 3.8x
CRBP ██% $194M x 1.9x
CRMD ██% $637M 3.4x 1.4x
CRNX ██% $8.97B x 7.5x
CRVO ██% $40M x 1.7x
CRVS ██% $1.19B x 5.3x
CTMX ██% $741M x 2.5x
CTNM ██% $623M x 2.6x
CTOR ██% $85M x 2.1x
CTTH ██% $3M x 4.5x
CTXR ██% $16M x 0.2x
CUE ██% $203M x 88.1x
CURX ██% $7M x 1.5x
CVKD ██% $5M x 1.2x
CVSI ██% $4M x 2.5x
CYCN ██% $17M x 3.3x
CYDY ██% $295M x x
CYPH ██% $181M x 1.3x
CYRX ██% $828M x 1.7x
CYTK ██% $10.68B x x
DARE ██% $16M x x
DCOY ██% $2M x 0.5x
DERM ██% $212M x 6.6x
DMAC ██% $352M x 9.2x
DMRA ██% $1.90B x 3.7x
DNTH ██% $6.09B x 5.2x
DRMA ██% $8M x 2.3x
DRUG ██% $756M x x
DSGN ██% $953M x 4.7x
DWTX ██% $86M x 1.3x
DYN ██% $4.93B x 7.0x
EBS ██% $261M x 0.8x
EDSA ██% $42M x 4.8x
ELAB ██% $5M x 0.3x
ELAN ██% $11.97B x 1.8x
ELDN ██% $276M x 8.4x
ELTP ██% $309M 5.5x 3.0x
ELTX ██% $78M x 9.9x
ELVN ██% $4.49B x 5.0x
EMMA ██% $3M x x
ENLV ██% $26M 0.0x 0.0x
ENSC ██% $7M x x
ENTA ██% $417M x 4.1x
ENVB ██% $6M x 0.8x
EOLS ██% $554M x x
EPRX ██% $444M x 5.4x
EQ ██% $140M x 2.5x
ERAS ██% $6.22B x 17.2x
ERNA ██% $6M x 1.8x
ESPR ██% $799M x x
ETON ██% $1.82B 143.7x 39.1x
ETST ██% $31M 7.0x 4.2x
EVFM ██% $1M x x
EVMN ██% $496M x 1.8x
EWTX ██% $4.83B x 10.8x
FBIO ██% $98M 0.9x 0.6x
FBLG ██% $9M x 1.9x
FBRX ██% $1.58B x 8.6x
FHTX ██% $403M x x
FLNA ██% $45M x 0.7x
FTH ██% $897M x 5.2x
FULC ██% $293M x 0.9x
GALT ██% $391M x x
GANX ██% $84M x 7.4x
GCAN ██% $250K 0.3x x
GDTC ██% $12M x x
GENB ██% $2.27B x 5.0x
GERN ██% $986M x 4.5x
GHRS ██% $1.74B x x
GLMD ██% $4M x 0.3x
GLSI ██% $245M x 78.5x
GNLX ██% $123M x 7.6x
GNPX ██% $3M x 0.2x
GOSS ██% $86M x x
GOVX ██% $4M x 2.0x
GPCR ██% $3.49B x 2.6x
GRCE ██% $46M x 1.0x
GRI ██% $4M x 0.4x
GRTX ██% $3.38B 22.7x 4646.0x
GSK ██% $103.71B x x
GTBP ██% $13M x 3.6x
GYRE ██% $701M x 6.5x
HCM ██% $2.12B 2.3x 1.7x
HCWB ██% $4M x 0.7x
HELP ██% $920M x x
HEPA ██% $6M x 4.3x
HIND ██% $16M x 2.6x
HOOK ██% $14M x 0.4x
HOWL ██% $42M x 2.6x
HRMY ██% $2.24B 12.3x 2.2x
HRTX ██% $61M x 8.8x
HSTC ██% $92M x 74.2x
HURA ██% $127M x 6.9x
HYFT ██% $66M x x
HYPD ██% $50M 7.5x 0.5x
IBIO ██% $71M x 0.9x
IBO ██% $49M 61.8x 4.5x
IDYA ██% $3.82B x 3.2x
IFRX ██% $309M x x
IGC ██% $31M x 5.0x
IMMP ██% $57M x x
IMMX ██% $974M x 4.3x
IMNM ██% $3.18B x 6.1x
IMNN ██% $9M x 2.2x
IMRN ██% $9M x x
IMRX ██% $335M x 1.8x
IMUX ██% $225M x 1.8x
INBP ██% $5M x 0.3x
INDP ██% $146M x 12.8x
INDV ██% $4.39B 14.2x x
INM ██% $8M x 1.1x
INO ██% $129M x 29.6x
INSM ██% $27.06B x 35.7x
INTI ██% $15M x x
INVA ██% $1.53B 3.8x 1.2x
IOBTQ ██% $10K x 0.0x
IONS ██% $10.28B x 23.4x
IRD ██% $333M x x
IRON ██% $3.10B x 4.8x
IRWD ██% $720M 5.5x x
ISCO ██% $4M x x
IVA ██% $1.11B x x
IXHL ██% $43M x 0.6x
JAGX ██% $4M x 0.6x
JANX ██% $1.06B x 1.2x
JAZZ ██% $16.08B 17.1x 3.4x
JBIO ██% $1.36B x 3.1x
JNJ ██% $657.32B 31.3x 7.7x
JUNS ██% $7M x x
KALA ██% $15M x 1.7x
KALV ██% $1.38B x x
KAPA ██% $5M x 1.2x
KAYS ██% $70K x x
KLRA ██% $2.14B x 1.9x
KMDA ██% $475M x x
KNSA ██% $6.07B 83.1x 10.0x
KPRX ██% $10M x 0.7x
KPTI ██% $44M x x
KROS ██% $228M x 0.9x
KRRO ██% $194M x 1.9x
KTTA ██% $17M x 0.3x
KURA ██% $1.10B x 22.8x
KYNB ██% $30M 0.2x x
LAB ██% $255M 3.0x 0.5x
LABT ██% $5M x 1.2x
LBRX ██% $1.56B x 4.7x
LEGN ██% $4.07B x x
LEXX ██% $17M x 3.7x
LFCR ██% $171M x x
LFVN ██% $86M 10.9x 2.6x
LGND ██% $5.70B 28.9x 5.9x
LGVN ██% $27M x 2.6x
LIANY ██% $12M x 0.1x
LIFD ██% $1M x 0.2x
LIPO ██% $0.00M x 0.0x
LITS ██% $36M x 0.6x
LIXT ██% $120M x 15.2x
LKFT ██% $1.91B x x
LLY ██% $1.12T 41.9x 33.1x
LNAI ██% $10M x x
LPCN ██% $17M x 0.8x
LQDA ██% $6.29B 45.4x 32.2x
LRMR ██% $421M x 3.3x
LSTA ██% $16M x 2.0x
LTRN ██% $27M x x
LXRX ██% $1.04B x 5.9x
LYEL ██% $345M x 1.5x
MAIA ██% $85M x 4.1x
MANE ██% $4.11B x 5.1x
MBIO ██% $4M x 0.6x
MBRX ██% $12M x 1.0x
MBX ██% $3.18B x 7.8x
MCRB ██% $45M x 1.3x
MDCX ██% $16M x x
MDGL ██% $11.77B x 22.5x
MEDS ██% $4M x 0.1x
MGNX ██% $261M x 6.1x
MIRA ██% $33M x 4.1x
MIRM ██% $6.35B x x
MIST ██% $145M x 8.0x
MLTX ██% $1.34B x 3.1x
MLYS ██% $2.33B x 4.2x
MNKD ██% $1.29B x x
MNOV ██% $75M x 2.0x
MNPR ██% $745M x 5.7x
MPLT ██% $509M x 1.5x
MREO ██% $46M x 1.6x
MRK ██% $376.80B 118.8x 9.0x
MRKR ██% $25M x 2.1x
MRVI ██% $3.12B x 15.3x
MSLE ██% $212M x x
MTNB ██% $3M x 1.6x
MTVA ██% $11M x 1.6x
NAMS ██% $3.16B x 5.0x
NATR ██% $252M 13.9x 1.5x
NBP ██% $231M x 0.9x
NBTX ██% $2.11B x x
NCEL ██% $20M x 36.6x
NCNA ██% $6M x x
NERV ██% $227M x x
NEUP ██% $21M x 0.7x
NGNE ██% $793M x 3.7x
NIKA ██% $442M x x
NKTR ██% $2.52B x 2.8x
NKTX ██% $193M x 0.8x
NMAD ██% $76M x 3.2x
NNVC ██% $32M x 3.5x
NRIX ██% $2.77B x 6.9x
NRSN ██% $14M x x
NRXP ██% $154M x x
NSRX ██% $48M x 17.3x
NTHI ██% $122M x x
NUVB ██% $2.34B x 9.2x
NUVL ██% $9.75B x 8.3x
NVCT ██% $779M x 85.8x
NVS ██% $301.53B x x
NWBO ██% $286M x x
NXTC ██% $27M x 2.3x
NXTS ██% $3M x 1.4x
OCUL ██% $2.43B x 4.7x
OGEN ██% $2M x 0.6x
OGI ██% $178M x x
OGN ██% $3.61B 17.3x 3.6x
OKUR ██% $157M x 0.9x
OLMA ██% $935M x 2.2x
OMER ██% $1.39B 11.2x x
ONC ██% $42.36B 64.6x 8.2x
ONCO ██% $2M x 0.2x
ONCY ██% $105M x x
OPK ██% $1.12B x 0.9x
ORGO ██% $215M x 1.5x
ORIC ██% $1.39B x 3.7x
ORKA ██% $6.25B x 5.6x
ORMP ██% $199M 1.1x 0.6x
OSTX ██% $72M x x
OTLC ██% $18M x 0.1x
OVID ██% $521M x 2.5x
OWPC ██% $10K x x
PAHC ██% $1.43B 15.0x 4.0x
PBH ██% $2.44B 14.2x 1.3x
PBM ██% $16M x x
PBYI ██% $466M 17.4x 3.4x
PCRX ██% $982M 67.1x 1.5x
PCSA ██% $6M x x
PCYN ██% $2M x 1.0x
PDSB ██% $12M x x
PEPG ██% $221M x 1.9x
PFE ██% $159.97B 36.9x 1.9x
PGEN ██% $2.58B x 59.2x
PHAT ██% $710M x x
PHIO ██% $14M x 1.1x
PHVS ██% $2.62B x x
PKTX ██% $80K x 0.3x
PLRX ██% $71M x 0.5x
PLYX ██% $93M x 8.5x
PMHS ██% $6M x x
PMN ██% $133M x 2.7x
PMVP ██% $70M x 1.0x
PPBT ██% $3M x x
PPCB ██% $3M x 0.3x
PRAX ██% $10.27B x 7.7x
PRFX ██% $3M x 0.4x
PRGO ██% $1.98B x 0.8x
PRLD ██% $528M x 4.0x
PRPH ██% $310K x x
PRQR ██% $330M x x
PRTA ██% $486M x 1.7x
PTCT ██% $5.92B x x
PTGX ██% $10.01B 120.7x 11.9x
PTIX ██% $2M x 1.2x
PTN ██% $18M x 1.7x
PTPI ██% $170K x 0.2x
PULM ██% $6M x 2.2x
PVCT ██% $25M x x
PVLA ██% $2.04B x 9.4x
PYXS ██% $257M x 22.5x
QNRX ██% $11M x 2.8x
QNTM ██% $21M x x
QTTB ██% $487M 14.4x 4.6x
QUCY ██% $110M x 5.4x
QURE ██% $2.99B x 20.0x
RADX ██% $19M x x
RANI ██% $124M x 3.2x
RAPP ██% $2.37B x 5.6x
RARE ██% $2.54B x x
RCKT ██% $387M x 1.1x
RCUS ██% $3.83B x 8.2x
RDY ██% $10.20B x x
REGN ██% $85.17B 19.7x 2.7x
REVB ██% $4M x 0.4x
RFL ██% $112M x 1.5x
RGBP ██% $170K x x
RIGL ██% $836M 2.6x 2.0x
RKTO ██% $17M x 2.0x
RLMD ██% $481M x 2.3x
RLYB ██% $89M 2.0x 0.9x
RMHI ██% $25M x x
RMTI ██% $32M x 0.9x
RNAC ██% $302M x x
RNAZ ██% $3M x x
RNTX ██% $67M x 1.2x
RNXT ██% $56M x 6.3x
ROIV ██% $26.28B x 6.2x
RPRX ██% $35.26B 43.3x 5.2x
RTEZ ██% $1.93B x x
RVPH ██% $7M x 0.4x
RVRC ██% $87M x 15.7x
RYTM ██% $7.67B x 74.5x
RZLT ██% $482M x 4.1x
SBFM ██% $4M x 0.2x
SCNX ██% $19M x 0.3x
SCYX ██% $52M x 0.8x
SDGR ██% $1.40B x 4.3x
SEPN ██% $1.82B x 4.7x
SER ██% $67M x 3.6x
SGMT ██% $631M x 2.5x
SHPH ██% $2M x 0.6x
SIGA ██% $213M x 1.3x
SILO ██% $5M x 0.9x
SION ██% $252M x 1.0x
SKVI ██% $970K x x
SKYE ██% $10M x x
SLGL ██% $251M x 11.0x
SLN ██% $826M x 21.5x
SLS ██% $2.89B x 21.0x
SMMT ██% $10.10B x 16.0x
SMNR ██% $143M x x
SNDX ██% $1.73B x 114.7x
SNGX ██% $9M x 1.3x
SNSE ██% $31M x x
SNY ██% $109.48B x x
SPRB ██% $157M x 1.9x
SPRC ██% $154M x x
SPRO ██% $71M 9.6x 1.6x
SPRY ██% $527M x 42.1x
SRPT ██% $1.94B 6.3x 1.3x
STOK ██% $2.02B x 5.8x
STTK ██% $796M x 3.8x
SUPN ██% $2.62B x 2.5x
SVRA ██% $1.14B x 8.0x
SXTP ██% $4M x 1.5x
SYBX ██% $14M x 1.2x
SYRE ██% $9.61B x 8.7x
TAK ██% $58.28B x x
TBPH ██% $882M 16.4x 3.1x
TCRT ██% $4M x 6.8x
TELO ██% $81M x 16.1x
TENX ██% $83M x 0.7x
TEVA ██% $42.93B 60.8x 5.5x
TGTX ██% $8.32B 18.8x 13.8x
TLPH ██% $63M x 4.3x
TLX ██% $3.96B x x
TNGX ██% $4.05B x 4.0x
TNXP ██% $224M x 1.0x
TOVX ██% $11M x 0.9x
TPST ██% $18M x x
TRDA ██% $291M x 1.3x
TRVI ██% $2.59B x 8.1x
TTRX ██% $289M x 420.4x
TVRD ██% $24M x 2.9x
TVTX ██% $6.13B x 249.8x
TXMD ██% $26M x 0.9x
TYRA ██% $1.61B x 4.5x
UNCY ██% $153M x 2.9x
UPB ██% $380M x 1.4x
URGN ██% $2.25B x x
UTHR ██% $22.15B 16.9x 3.5x
VBIO ██% $630K x 0.2x
VCNX ██% $3M x x
VERA ██% $2.49B x 6.1x
VGLS ██% $240K x x
VICP ██% $47M x x
VKTX ██% $3.85B x 9.4x
VNDA ██% $320M x 1.5x
VRCA ██% $85M x 19.6x
VRDN ██% $2.75B x 4.2x
VREOD ██% $491M x 1.7x
VREOF ██% $491M x 1.7x
VRTX ██% $139.15B 31.6x 6.9x
VSTM ██% $645M x 12.9x
VTGN ██% $10M x 0.4x
VTRS ██% $19.29B 7.3x 1.4x
VYNE ██% $19M x 0.8x
WHWK ██% $283M x 1.6x
WVE ██% $1.03B x 2.3x
XBIO ██% $9M x 1.5x
XBIT ██% $69M x 0.5x
XCUR ██% $7M x 7.4x
XENE ██% $5.86B x 4.7x
XERS ██% $1.52B x x
XLO ██% $61M x 0.8x
XNCR ██% $2.19B x 4.4x
XOMA ██% $710M 21.0x 7.7x
XTLB ██% $6M x x
ZBIO ██% $2.01B x 8.2x
ZLAB ██% $2.95B x 4.9x
ZNTL ██% $360M x 2.5x
ZTS ██% $31.94B 12.2x 10.2x
ZVRA ██% $695M 11.3x 3.2x
ZVSA ██% $810K x x
Reveal all forecasts See exact % predictions for all competitors
Sign up free

Frequently Asked Questions - Bio-Path Holdings, Inc. Stock Forecast

How accurate are Bio-Path Holdings, Inc. stock predictions?

Our AI model shows a 2% Spearman correlation coefficient for BPTH predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Bio-Path Holdings, Inc. stock price forecasts?

Our analysis considers Bio-Path Holdings, Inc.'s financial metrics, Life Sciences sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Bio-Path Holdings, Inc. a good investment in 2026?

Based on our AI analysis, Bio-Path Holdings, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Bio-Path Holdings, Inc. forecasts updated?

Bio-Path Holdings, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want a simpler view of Bio-Path Holdings, Inc.?

View simplified analysis on AI Stock Finder →

My Portfolio

Investment Dashboard

Loading your portfolio...